Skip to content

NIAGEN BIOSCIENCE, INC.: 10-Q filed 2017-11-09

What NIAGEN BIOSCIENCE, INC. reported in its quarterly report filed 2017-11-09 (fiscal Q3 2017): 40 published measures, 111 facts as tagged in accession 0001654954-17-010302.

This filing

Form
10-Q (quarterly report)
Filed
2017-11-09
Fiscal period
fiscal Q3 2017
Accession
0001654954-17-010302 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NIAGEN BIOSCIENCE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-09-3041,801,512USD
At 2016-12-3119,752,068USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2017-09-308,063,671USD
At 2016-12-319,777,710USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-09-3033,737,841USD
At 2017-07-0125,719,423USD
At 2017-04-019,372,058USD
At 2016-12-319,974,358USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-07-02 to 2017-09-302,137,077USD91
2017-01-01 to 2017-09-30-2,555,802USD273
2017-04-02 to 2017-07-01-2,764,124USD91
2017-01-01 to 2017-04-01-1,928,755USD91
2016-07-03 to 2016-10-01-954,390USD91
2016-01-03 to 2016-10-01-781,432USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-6,037,201USD273
2016-01-03 to 2016-10-01-3,127,782USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-01-01 to 2017-09-30872,215USD273
2016-01-03 to 2016-10-01940,978USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2017-01-01 to 2017-09-3023,497,188USD273
2016-01-03 to 2016-10-01988,844USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-01-01 to 2017-09-304,897,217USD273
2016-01-03 to 2016-10-01-1,145,978USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-09-30-47,779,376USD
At 2016-12-31-45,223,574USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2017-07-02 to 2017-09-3047,065,009shares91
2017-01-01 to 2017-09-3042,405,616shares273
2016-07-03 to 2016-10-0137,868,672shares91
2016-01-03 to 2016-10-0137,090,916shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2017-07-02 to 2017-09-3047,556,697shares91
2017-01-01 to 2017-09-3042,405,616shares273
2016-07-03 to 2016-10-0137,868,672shares91
2016-01-03 to 2016-10-0137,090,916shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2017-07-02 to 2017-09-300.05USD/shares91
2017-01-01 to 2017-09-30-0.06USD/shares273
2016-07-03 to 2016-10-01-0.03USD/shares91
2016-01-03 to 2016-10-01-0.02USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2017-07-02 to 2017-09-300.04USD/shares91
2017-01-01 to 2017-09-30-0.06USD/shares273
2016-07-03 to 2016-10-01-0.03USD/shares91
2016-01-03 to 2016-10-01-0.02USD/shares273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-01-01 to 2017-09-300USD273
2016-01-03 to 2016-10-01-3,500USD273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-09-302,690,527USD
At 2016-12-311,778,171USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2017-07-02 to 2017-09-30490,817USD91
2017-04-02 to 2017-07-01399,861USD91
2017-01-01 to 2017-04-01319,830USD91

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-07-02 to 2017-09-30-3,176,784USD91
2017-01-01 to 2017-09-30-7,599,179USD273
2016-07-03 to 2016-10-01-924,162USD91
2016-01-03 to 2016-10-01-733,284USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-09-3036,259,034USD
At 2016-12-3115,736,943USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2017-07-02 to 2017-09-3044,508USD91
2017-01-01 to 2017-09-30108,751USD273
2016-07-03 to 2016-10-012,260USD91
2016-01-03 to 2016-10-01314,926USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-09-307,209,188USD
At 2016-12-318,869,150USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2017-09-304,346,700USD
At 2016-12-315,978,288USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-09-304,919,768USD
At 2016-12-315,852,030USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-07-02 to 2017-09-306,092,153USD91
2017-01-01 to 2017-09-3014,241,485USD273
2016-07-03 to 2016-10-012,787,123USD91
2016-01-03 to 2016-10-019,113,749USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-09-306,615,245USD
At 2016-12-317,912,630USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-07-02 to 2017-09-302,915,369USD91
2017-01-01 to 2017-09-306,642,306USD273
2016-07-03 to 2016-10-011,862,961USD91
2016-01-03 to 2016-10-018,380,465USD273

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2017-07-02 to 2017-09-303,169,321USD91
2017-01-01 to 2017-09-307,028,340USD273
2016-07-03 to 2016-10-012,074,325USD91
2016-01-03 to 2016-10-018,831,400USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-07-02 to 2017-09-301,040,561USD91
2017-01-01 to 2017-09-302,554,713USD273
2016-07-03 to 2016-10-01772,799USD91
2016-01-03 to 2016-10-011,988,597USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-09-3047,650,252shares
At 2016-12-3137,544,531shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-09-3081,469,567USD
At 2016-12-3155,160,387USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2017-09-301,709,609USD
At 2016-12-31486,226USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2017-09-302,129,583USD
At 2016-12-312,170,172USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-7,707,930USD273
2016-01-03 to 2016-10-01-1,361,309USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-07-02 to 2017-09-303,948,435USD91
2017-01-01 to 2017-09-308,882,821USD273
2016-07-03 to 2016-10-011,727,383USD91
2016-01-03 to 2016-10-015,935,139USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-01-01 to 2017-09-30396,000USD273
2016-01-03 to 2016-10-01234,408USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-01-01 to 2017-09-30148,005USD273
2016-01-03 to 2016-10-0163,116USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2017-07-02 to 2017-09-30-44,508USD91
2017-01-01 to 2017-09-30-108,751USD273
2016-07-03 to 2016-10-01-2,260USD91
2016-01-03 to 2016-10-01-628,025USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2017-01-01 to 2017-09-3043,912USD273
2016-01-03 to 2016-10-01251,231USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2017-01-01 to 2017-09-3023,713,762USD273
2016-01-03 to 2016-10-015,717,474USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-301,358,299USD273
2016-01-03 to 2016-10-011,840,572USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2017-01-01 to 2017-09-30-1,735,361USD273
2016-01-03 to 2016-10-01-2,125,180USD273

Inspect the source

Entity
NIAGEN BIOSCIENCE, INC. / CIK 0001386570
Captured
2026-09-20T07:59:02.162Z
SEC response SHA-256
94352bf8b6f04074c9aa98cd63fa97055bc3335ae039584aee12f63320ac36f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001386570.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))